- Home
- VITL vs JANX Comparison
VITL vs JANX Comparison
Compare VITL & JANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VITL | JANX |
|---|---|---|
| Founded | 2007 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 944.3M | 790.3M |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | VITL | JANX |
|---|---|---|
| Price | $20.04 | $13.77 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 11 |
| Target Price | $42.56 | ★ $53.60 |
| AVG Volume (30 Days) | ★ 2.1M | 905.9K |
| Earning Date | 01-01-0001 | 06-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 22.03 | N/A |
| EPS | ★ 1.44 | N/A |
| Revenue | ★ $759,444,000.00 | $10,000,000.00 |
| Revenue This Year | $26.07 | N/A |
| Revenue Next Year | $20.95 | $209.90 |
| P/E Ratio | $13.90 | ★ N/A |
| Revenue Growth | ★ 25.26 | N/A |
| 52 Week Low | $19.75 | $12.12 |
| 52 Week High | $53.13 | $35.34 |
Technical Indicators
Market Signals| Indicator | VITL | JANX |
|---|---|---|
| Relative Strength Index (RSI) | 23.17 | 52.19 |
| Support Level | N/A | $13.80 |
| Resistance Level | $31.02 | $15.49 |
| Average True Range (ATR) | 1.24 | 0.54 |
| MACD | -0.58 | 0.16 |
| Stochastic Oscillator | 3.04 | 65.91 |
Price Performance
Historical ComparisonAbout VITL Vital Farms Inc.
Vital Farms Inc is an ethical food company. The company retails pasture-raised eggs and butter. Its products include Pasture-Raised Eggs and Pasture-Raised Butter & Ghee. The company's purpose is rooted in a commitment to Conscious Capitalism, which prioritizes the long-term benefits of its stakeholders (farmers and suppliers, customers and consumers, communities and the environment, employees, and stockholders).
About JANX Janux Therapeutics Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. Its proprietary technology has enabled the development of two distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr). The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.